Table 1.

Participant demographics

	Non-HAND (n=84)	HAND (n=50)	p value
Age, years, mean (SD)	38.65(9.46)	36.77(7.91)	NS
Male, n (%)	65(77.38)	11(22)	<0.001
Education, years, mean (SD)	5.23(1.46)	4.85(1.24)	NS
Race/ethnicity — minority, n (%)	6(7.14)	3(6)	NS
Estimated infective time, years, mean (SD)	4.63(2.68)	5.16(3.24)	NS
ART treatment time, months, mean (SD)	13.26(3.25)	12.03(4.78)	NS
HIV infection risks
MSM, n (%)	14(16.67)	8(16)	NS
IDU, n (%)	8(9.52)	3(6)	NS
Heterosexual, n (%)	27(32.14)	17(34)	NS
FPD, n (%)	32(38.1)	20(40)	NS
Others, n (%)	3(3.57)	2(4)	NS

HAND HIV-associated neurocognitive disorders, ART antiretroviral therapy, MSM men who have sex with men, IDU injecting drug user, FPD former plasma donors, NS non-significant at p<0.05